FINNENCE ▪ THE WIRE FILE
THE WIRE · № 71010
News■ Unclear/unknown
Nvidia-backed Iambic Therapeutics targets up to $806 million valuation in US IPO
KINDNews
DIRECTION■ Unclear/unknown
SOURCES1
ENTITIES2
STORY SIZESTANDALONE
FIRST SEEN2026-10-08 12:08 UTC
LAST UPDATE2026-10-08 12:08 UTC
STATEactive
01 THE MACHINE READ
WHY IT MATTERS.
Another Nvidia-backed biotech IPO tests appetite for AI-adjacent listings at rich valuations.
AI-linked IPO pipeline stays warm
CATALYST TO WATCH
Pricing and first-day trading
MAIN RISK
Weak debut could cool AI IPO demand
02 THE STORY SO FAR
THE RECORD, IN ORDER.
STANDALONE ITEM — NOT YET FOLDED INTO A DEVELOPING STORY.
03 WHO'S INVOLVED
ENTITIES ON FILE.
BACKERNVIDIA · NVDA
AFFECTEDAI
04 RECEIPTS
THE SOURCE RECORD.
1 SOURCES CONFIRMED05 PROPAGATION
WHAT THIS TOUCHES.
→CORRELATIONshares AI
Exclusive: Sam Altman-backed Meanwhile raises $37.5M at $350M valuation2026-10-08 12:21 UTC
Exclusive: Sam Altman-backed Meanwhile raises $37.5M at $350M valuation2026-10-08 12:21 UTC
→CORRELATIONshares AI
Fed’s Waller signals further rate hikes as inflation stalls, AI spending drives up costs2026-10-08 12:34 UTC
Fed’s Waller signals further rate hikes as inflation stalls, AI spending drives up costs2026-10-08 12:34 UTC
→CORRELATIONshares AI
APLD Stock Gets Target Hike From Wells Fargo Post Earnings - Analyst Sees Debt Raises For Meta Leases, 250 MWs Expansion As Catalysts Ahead2026-10-08 12:19 UTC
APLD Stock Gets Target Hike From Wells Fargo Post Earnings - Analyst Sees Debt Raises For Meta Leases, 250 MWs Expansion As Catalysts Ahead2026-10-08 12:19 UTC
KEEP READING THE MACHINE
Summaries are generated and may contain errors — every claim links its sources.